Overview
Status
Active
Registry date
2019-01-31
Share capital
5 000,00 PLN
Registered address
Aleje Jerozolimskie 25, 00-508 Warszawa, Poland
Electronic delivery address
AE:PL-84463-61013-FISAB-21
Financials
Revenue history (in k)
Filing timeliness
No financial statement for 2024 – the filing deadline has passed. 5 of 5 financial statements were filed late (the longest delay 1236 days for 2019).
- 2024not filed
- 202330/09/2024
- 202230/09/2024
- 202104/03/2024
- 202004/03/2024
- 201904/03/2024
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2023.
Results vs industry
Revenue
This companyUSD 173.60kMedianUSD 38.63kAverageUSD 150.37k
Net profit
This companyUSD 37.85kMedianUSD 333.84AverageUSD 12.60k
Operating costs
This companyUSD 135.71kMedianUSD 39.19kAverageUSD 133.48k
Assets
This companyUSD 10.34kMedianUSD 16.85kAverageUSD 103.52k
Industry
Authorized Representatives
Gaifeng Li – Prezez Zarządu
Manner of representation
Each member of the management board is authorised to make declarations on behalf of the company independently
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Gaifeng Liage 54 | 40 | $540.25 | 40% |
Daqing Quage 61 | 20 | $270.12 | 20% |
Aiqing Zhang | 40 | $540.25 | 40% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2020-01-14.
No bank accounts reported to the VAT Taxpayer Register.
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Cross Medica Szczepkowscysp. k. | $2,359,440.46 | crossmedica2.pl | ||
| Heliconsp. z o.o. | $276,987.08 | helicon.com.pl | ||
| Onenesssp. z o.o. | $232,088.78 | oneness.pl | ||
| Phtisp. z o.o. | $193,356.82 | maksymkomar.com | ||
| Salvomed Kolumna Transportu Sanitarnegosp. z o.o. | $169,888.93 | salvomed.pl | ||
| Naturiana Paulina Szpakowska-Kurczynsp. z o.o. | $125,131.27 | naturiana.pl | ||
| 21 Stópsp. z o.o. | $57,428.79 | architec.pl | ||
| Manuartissp. z o.o. | $50,092.92 | manuartis.pl | ||
| Holistic Housesp. z o.o. | $0.00 | holihouse.pl | ||
| Pillar Kloceksp. j. | – | pillar-pharma.pl |
Change history
| Date | Event | |
|---|---|---|
| 2025-03-27 | Address change (Ul. Puławska 39, 02-508, Warszawa → Aleje Jerozolimskie 25, 00-508, Warszawa) | |
| 2021-03-04 | PKD change (Added: 46, 47) | |
| 2021-01-19 | Name change (Beijing Noah Defu Pharmaceutical Technology Co.ltd → Beijing Noah Defu Pharmaceutical Technology) | |
| 2021-01-19 | PKD change (Added: 49.41.Z, 52, 53, 68.10.Z) | |
| 2020-02-20 | Address change (Ul. Jana Pawła Ii 27, 00-867, Warszawa → Ul. Puławska 39, 02-508, Warszawa) |
FAQ
The main business activity of Beijing Noah Defu Pharmaceutical Technology focuses on paramedical activities.
The company was registered in the Polish National Court Register (KRS) on January 31, 2019.
The headquarters is located at: Aleje Jerozolimskie 25, 00-508 Warszawa.
The share capital of the company is PLN 5,000 (approx. $1,351).
The latest available financial statement covers the period from January 1, 2023 to December 31, 2023.
In 2023, the company generated total revenue of $173,597, representing an increase of 60.5% compared to 2022.
Yes, in 2023 the company achieved a net profit of $37,846.
The largest operating cost category falls under external services. This category amounted to $56,902 in 2023, representing 42% of all operating expenses.
Last updated: 2026-04-10